Dr. Francine Fang has been active in healthcare venture investment since 2008. She is a founding partner of 3E Bioventures. Before 3E, Dr. Fang was a partner at Fidelity Growth Partners Asia and Tuspark Venture. Prior to her investment career, she worked at Clontech(acquired by BD Biosciences).
Dr. Fang received her Ph.D. in Physiology and Neuroscience from Rutgers University and M.D. degree from Capital Institute of Medicine in Beijing, China.